Charles Quesenberry to Simvastatin
This is a "connection" page, showing publications Charles Quesenberry has written about Simvastatin.
Connection Strength
0.019
-
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf. 2008 Jan; 17(1):27-36.
Score: 0.019